Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

NYSE:MPW - New York Stock Exchange, Inc. - US58463J3041 - REIT - Currency: USD

4.46  -0.04 (-0.89%)

After market: 4.45 -0.01 (-0.22%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MPW. MPW was compared to 128 industry peers in the Diversified REITs industry. Both the profitability and financial health of MPW have multiple concerns. MPW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MPW had negative earnings in the past year.
In the past year MPW had a positive cash flow from operations.
In multiple years MPW reported negative net income over the last 5 years.
In the past 5 years MPW always reported a positive cash flow from operatings.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

Looking at the Return On Assets, with a value of -11.13%, MPW is doing worse than 95.31% of the companies in the same industry.
MPW has a Return On Equity of -34.74%. This is amonst the worse of the industry: MPW underperforms 92.97% of its industry peers.
With a Return On Invested Capital value of 1.88%, MPW is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
MPW had an Average Return On Invested Capital over the past 3 years of 2.26%. This is in line with the industry average of 3.14%.
Industry RankSector Rank
ROA -11.13%
ROE -34.74%
ROIC 1.88%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 35.82%, MPW is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
MPW's Operating Margin has declined in the last couple of years.
MPW has a better Gross Margin (96.89%) than 97.66% of its industry peers.
MPW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.82%
PM (TTM) N/A
GM 96.89%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

MPW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MPW has more shares outstanding
MPW has more shares outstanding than it did 5 years ago.
MPW has a worse debt/assets ratio than last year.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.01, we must say that MPW is in the distress zone and has some risk of bankruptcy.
MPW's Altman-Z score of 0.01 is on the low side compared to the rest of the industry. MPW is outperformed by 76.56% of its industry peers.
A Debt/Equity ratio of 1.99 is on the high side and indicates that MPW has dependencies on debt financing.
With a Debt to Equity ratio value of 1.99, MPW is not doing good in the industry: 72.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.99
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACC0.3
WACC6.24%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 2.38 indicates that MPW has no problem at all paying its short term obligations.
MPW's Current ratio of 2.38 is amongst the best of the industry. MPW outperforms 83.59% of its industry peers.
MPW has a Quick Ratio of 2.38. This indicates that MPW is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.38, MPW belongs to the best of the industry, outperforming 83.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 2.38
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

MPW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1304.35%.
Looking at the last year, MPW shows a quite strong growth in Revenue. The Revenue has grown by 19.56% in the last year.
The Revenue has been growing slightly by 3.11% on average over the past years.
EPS 1Y (TTM)-1304.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.71%
Revenue 1Y (TTM)19.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-17.51%

3.2 Future

The Earnings Per Share is expected to grow by 27.85% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -0.37% on average over the next years.
EPS Next Y100.15%
EPS Next 2Y43.88%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue Next Year-2.6%
Revenue Next 2Y2.14%
Revenue Next 3Y3.9%
Revenue Next 5Y-0.37%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
MPW is valuated rather expensively with a Price/Forward Earnings ratio of 24.09.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MPW indicates a rather cheap valuation: MPW is cheaper than 82.03% of the companies listed in the same industry.
MPW's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.49.
Industry RankSector Rank
PE N/A
Fwd PE 24.09
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

MPW's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.71
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MPW's earnings are expected to grow with 27.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.88%
EPS Next 3Y27.85%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.11%, MPW is a good candidate for dividend investing.
The stock price of MPW dropped by -26.16% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
MPW's Dividend Yield is a higher than the industry average which is at 6.79.
MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 7.11%

5.2 History

The dividend of MPW decreases each year by -10.38%.
MPW has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-16.72%
EPS Next 2Y43.88%
EPS Next 3Y27.85%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

More info and screens

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (6/27/2025, 8:04:00 PM)

After market: 4.45 -0.01 (-0.22%)

4.46

-0.04 (-0.89%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners60.69%
Inst Owner Change-3.14%
Ins Owners17.33%
Ins Owner Change11.27%
Market Cap2.68B
Analysts52.22
Price Target5.32 (19.28%)
Short Float %35.3%
Short Ratio18.65
Dividend
Industry RankSector Rank
Dividend Yield 7.11%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-16.72%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-18 2025-06-18 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6414.34%
Min EPS beat(2)-11757.5%
Max EPS beat(2)-1071.21%
EPS beat(4)0
Avg EPS beat(4)-3998.5%
Min EPS beat(4)-11757.5%
Max EPS beat(4)-653.07%
EPS beat(8)1
Avg EPS beat(8)-1972.17%
EPS beat(12)3
Avg EPS beat(12)-1334.35%
EPS beat(16)6
Avg EPS beat(16)-987.1%
Revenue beat(2)1
Avg Revenue beat(2)0.96%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)5.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)5.9%
Revenue beat(8)3
Avg Revenue beat(8)-1.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.93%
Revenue beat(16)6
Avg Revenue beat(16)-1.32%
PT rev (1m)-3.95%
PT rev (3m)14.29%
EPS NQ rev (1m)220.05%
EPS NQ rev (3m)123.08%
EPS NY rev (1m)128.57%
EPS NY rev (3m)102.45%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)1.4%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)2.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.09
P/S 2.83
P/FCF N/A
P/OCF 15.62
P/B 0.56
P/tB 0.56
EV/EBITDA 14.71
EPS(TTM)-2.77
EYN/A
EPS(NY)0.19
Fwd EY4.15%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.29
OCFY6.4%
SpS1.58
BVpS7.92
TBVpS7.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.13%
ROE -34.74%
ROCE 2.38%
ROIC 1.88%
ROICexc 1.98%
ROICexgc 2.05%
OM 35.82%
PM (TTM) N/A
GM 96.89%
FCFM N/A
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexcg growth 3Y-18.25%
ROICexcg growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.99
Debt/FCF N/A
Debt/EBITDA 12.11
Cap/Depr 49.98%
Cap/Sales 23.3%
Interest Coverage 0.84
Cash Conversion 21.95%
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 2.38
Altman-Z 0.01
F-Score5
WACC6.24%
ROIC/WACC0.3
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1304.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-185.71%
EPS Next Y100.15%
EPS Next 2Y43.88%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue 1Y (TTM)19.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-17.51%
Revenue Next Year-2.6%
Revenue Next 2Y2.14%
Revenue Next 3Y3.9%
Revenue Next 5Y-0.37%
EBIT growth 1Y1491.35%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year124.47%
EBIT Next 3Y38.21%
EBIT Next 5YN/A
FCF growth 1Y31.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.33%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%